Healthy children may be eligible to participate in a research study evaluating an investigational vaccine to prevent meningitis and other serious infections caused by the meningococcus B germ.

Qualifying participants receive compensation for time and travel for completed visits.

Eligibility Requirements

Your child may be eligible for this study if he or she is:

• Healthy
• Between 11 and 17 years old
• Available for five study visits over a 14-month period
• Without any chronic illness/illnesses
• Never received the human papilloma virus vaccine (Gardasil)

For more information, call 919-620-5354.